Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep 29:2022:8756308.
doi: 10.1155/2022/8756308. eCollection 2022.

Serologic Presentation of Lamotrigine-Induced Lupus

Affiliations
Case Reports

Serologic Presentation of Lamotrigine-Induced Lupus

Hannah Dempsey et al. Case Rep Neurol Med. .

Abstract

This paper discusses the presentation of a rare drug side effect, a case of drug-induced lupus presenting with weight loss, weakness, hepatitis, and pancreatitis. A 24-year-old male with a history of major depressive disorder and childhood seizures presented to the ER with symptoms of abdominal pain, significant weight loss, and weakness. Initial workup revealed acute pancreatitis, elevated liver function enzymes (LFTs), and abnormal anti-double-stranded DNA antibody (anti-dsDNA) 1 : 640. He showed no classical clinical signs of lupus including rash, arthritis, or photosensitivity. He had multiple hospitalizations in the previous 6 months for excessive weight loss, malnutrition, weakness, and altered mental status. He had been taking lamotrigine for seizure prevention and mood stabilization while on a selective serotonin reuptake inhibitor (SSRI) and had a decline in health since the lamotrigine dose was increased. Antihistone antibodies were positive suggesting a drug-induced lupus syndrome. We hope to bring awareness to the possible rare complication of lamotrigine-induced lupus.

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no conflicts of interest.

References

    1. SLE criteria: SLICC. 2021. https://sliccgroup.org/research/sle-criteria/
    1. How is drug-induced lupus erythematosus (DILE) differentiated from systemic lupus erythematosus (SLE)? 2021. https://www.medscape.com/answers/1065086-113763/how-is-drug-induced-lupu... .
    1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury . Bethesda, MD, USA: National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Adverse drug reaction probability scale (naranjo) in drug induced liver injury. https://www.ncbi.nlm.nih.gov/books/NBK548069/ - PubMed
    1. Batra J., Kaur S., Kaushal S., Singh A. Lamotrigine-induced systemic lupus erythematosus: a diagnostic dilemma. Indian Dermatology Online Journal . 2018;9(6):445–447. doi: 10.4103/idoj.idoj_24_18. - DOI - PMC - PubMed
    1. Ravindran V. Lamotrigine-induced lupus: a case report. International Journal of Rheumatic Diseases . 2011;14(3):e47–e48. doi: 10.1111/j.1756-185x.2011.01634.x. - DOI - PubMed

Publication types

LinkOut - more resources